HCW Biologics announces pricing of $6.9M registered direct offering, concurrent private placement

nan_bkk/iStock via Getty Images HCW Biologics ( NASDAQ: HCWB ) has entered into a securities purchase agreement with a single institutional investor to purchase 6.7M shares in a registered direct offering priced above market, the company said Monday after the bell. In a concurrent private placement, HCW Biologics (.